Dr. Ecevit Bilgili is currently an associate professor of Chemical Engineering at NJIT. His Particle Engineering and Pharmaceutical Nanotechnology Lab (PEPNAL) has been conducting research in designing particulate formulations and processes for high-value-added products like pharmaceuticals with enhanced functionalities such as enhanced bioavailability of poorly water-soluble drugs. His research interests center on the development of a fundamental understanding of the mechanisms–transformations involved during the formation of drug nanoparticles via top-down and bottom-up approaches, nanocomposite microparticles, and amorphous solid dispersions. His research group uses experimentation coupled with population balance modeling (PBM), discrete element modeling (DEM), and microhydrodynamic modeling in a unique multi-scale approach to elucidate complex non-linear rate processes. Prior to this academic position, Dr. Bilgili worked as Principal Development Engineer within R&D and Pharmaceutical Commercialization Technology Department at Merck & Co., Inc during 2004–2009. Before Merck years, he had worked as a post-doctoral research associate at the Particle Engineering Research Center, University of Florida.
Dr. Bilgili is a well-recognized member of the Particle Technology Community. He served as an elected Executive Committee Member of the Particle Technology Forum of AIChE. He also served as the Chair & Vice-Chair of AIChE Area3a: Particle Production and Characterization and as a project leader for Project A1: Particle Formation within the NSF ERC for Structured Organic Particulate Systems. He has authored 70+ peer-reviewed journal articles, 4 U.S. patents, 2 provisional patents, and several invention disclosures. He delivered 80+ national/international presentations and 22 invited talks. He has served as a referee to 20 engineering and pharmaceutics journals, as a chair/co-chair in 30+ sessions of national/international conferences, and as a senior member of AIChE and ACS. He was one of the organizers of the Topical Conference titled “Pharmaceutical Engineering for the 21st Century” at the AIChE Annual Meeting in 2007. He is the recipient of the Best PhD Thesis in Particle Technology Award from AIChE in 2004, Who’s Who in Science and Engineering, and Who’s Who in Emerging Leaders as well as NJIT’s Excellence in Teaching Award. His research has been funded by NSF ERC, NIH/FDA, Boehringer-Ingelheim, Catalent Pharma Solutions, International Flavors & Fragrances, Nisso America, and Siam Research and Innovation Co.